Sorli C, Harashima S-I, Tsoukas GM et al (2017) Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Selecting it triggered a pop-up offering a $178/mo retention discount and asking for a reason
Regardless of the reason, consult with your provider if youre considering changing your Wegovy dosage
Researchers in BMJ reviewed almost 10,000 reports of the use of weight loss medications or behavioral programs, and identified 37 studies with low risk of bias (with 9,431 participants) on which to perform a meta-analysis
At MARC, weve built the right setup to manage these challenges with confidence